Zobrazeno 1 - 10
of 641
pro vyhledávání: '"C.J.A. Punt"'
Autor:
C.J.A. Punt, V. Heinemann, T. Maughan, C. Cremolini, E. Van Cutsem, R. McDermott, G. Bodoky, T. André, P. Osterlund, A.J. Teske, P. Pfeiffer
BACKGROUND: Fluoropyrimidines (FPs) are an essential part of the majority of systemic regimens in the treatment of metastatic colorectal cancer (CRC). The use of the oral FP S-1 has been approved by the European Medicines Agency as monotherapy or in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39f40088f1dd2a8e34b10c1e576b40c
https://lirias.kuleuven.be/handle/20.500.12942/720325
https://lirias.kuleuven.be/handle/20.500.12942/720325
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Roodhart, K. Zwart, C.J.A. Punt, E. Wensink, K. Bolhuis, M.M. Laclé, W. van Grevenstein, J. Hagendoorn, I.H.J.T. de Hingh, M. Koopman, G. Vink, F. van der Baan
Publikováno v:
Annals of Oncology. 33:S704-S705
Autor:
Andrés Cervantes, H.P. Knol, L. Østergaard, M.L. Lydrup, S.A. Radema, R.F. Schmitz, P. Nieboer, J. Hol, I. Edhemovic, K.C.M.J. Peeters, A. Johnsson, F.J.F. Jeurissen, Pieter J. Tanis, A.C.M. van de Luijtgaarden, P. Quarles an Ufford, H. Kim, Hein Putter, W.A. Bleeker, Tone Fokstuen, M E van Leerdam, K. Kovacs, A. Pronk, E.D. Kerver, L.G.H. Dewit, E. Garcia Granero, P.A. Nijenhuis, T. Fokstuen, S. Ottosson, P. Flygare, M.J. Safont, Iris D. Nagtegaal, F. Svendsen Jensen, C. Bratthäll, H.M. Ceha, L. Malmberg, P. Hede, W.M. van der Deure, G. Carlsson, J. Haux, Derk Jan A. de Groot, Esmée A Dijkstra, Renu R. Bahadoer, G.A.P. Nieuwenhuijzen, B. de Valk, B. Lindh, D. Hess, G.L. Beets, J.C. Bernal, A.M.E. Bruynzeel, R.M.P.H. Crolla, C. Kersten, P. Pfeiffer, S. Biondo, M.L. Silviera, Jannet C. Beukema, W.H. Schreurs, O. Hallböök, B.L. Lödén, A. Espí Macías, V. Velenik, L. Österlund, A. Slot, Geke A. P. Hospers, H. de Wilt, A.W.K.S. Marinelli, O. Lundberg, C. Radu, J. die Trill, I. Verbiené, P. Matthiessen, Mathijs P. Hendriks, J.H.M. Bekker, M. Walldén, V. Pachón, H.W. Kapiteijn, J.M. Immink, A. Piwowar, R. Salazar, L. Påhlman, P. Braam, K.E.J. Jensen, S. Festen, O. Mjåland, Elma Meershoek-Klein Kranenbarg, Jaume Capdevila, U. Palenius, K. Villmann, J.J. van der Vliet, Albert J. ten Tije, A. Berglund, Corrie A.M. Marijnen, G. Dafnis, J. Assarsson, J. Capdevila, J.W.T. Dekker, M. Grønlie Guren, G.J. Veldhuis, Q.A.J. Eijsbouts, G.J. Creemers, J.B. Tuynman, C.J.A. Punt, P.H.J.M. Veldman, J. Aparicio, Klaas Havenga, E.D. Geijsen, W.H. Steup, T. Rozema, K. Smedh, Lennart Blomqvist, J. de Boer, Cornelis J.H. van de Velde, S. Jangmalm, J.W.P. Vanstiphout, T.C. Stam, A.C.M. van den Bergh, Annet G H Roodvoets, Janet R. Vos, E.J.M. Siemerink, R.J.I. Bosker, Bengt Glimelius, A. Cervantes, E. Espin, Per Nilsson, A.J. Ten Tije, Ibrahim Edhemovic, Boudewijn van Etten, M. Tascilar, A.N. Nesbakken, G.A. Patijn, O. Reerink, Regina G. H. Beets-Tan, S. Skullman, H. Hörberg, P. Parinkh, G. Svaninger, M.B. Polée, D. Ten Bokkel Huinink, C. Hoff, A.F.T. Olieman, H. van den Berg, F.P. Peters, Torbjörn Holm, J.M. van Rooijen, M.P. Hendriks, J. Benedik, J.H. Svensson, A.L.T. Imholz
Publikováno v:
Lancet Oncology, 22, 29-42
Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045(20)30555-6
The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
The Lancet. Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Lancet Oncology, 22, 1, pp. 29-42
The Lancet Oncology, 22(1), 29-42. ELSEVIER
The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group
lancet oncology, 22(1), 29-42. Lancet Publishing Group
Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045(20)30555-6
The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
The Lancet. Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Lancet Oncology, 22, 1, pp. 29-42
The Lancet Oncology, 22(1), 29-42. ELSEVIER
The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group
lancet oncology, 22(1), 29-42. Lancet Publishing Group
BACKGROUND: Systemic relapses remain a major problem in locally advanced rectal cancer. Using short-course radiotherapy followed by chemotherapy and delayed surgery, the Rectal cancer And Preoperative Induction therapy followed by Dedicated Operation
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P. Osterlund, S. Kinos, P. Pfeiffer, T. Salminen, J.J.M. Kwakman, J.-E. Frödin, C.H. Shah, H. Sorbye, R. Ristamäki, P. Halonen, L.M. Soveri, E. Heervä, A. Ålgars, M. Bärlund, H. Hagman, R. McDermott, M. O’Reilly, R. Röckert, G. Liposits, R. Kallio, P. Flygare, A.J. Teske, E. van Werkhoven, C.J.A. Punt, B. Glimelius
Publikováno v:
ESMO open, 7(3):100427. Elsevier BV
ESMO Open
ESMO Open
Publisher Copyright: © 2022 The Author(s) Background: Capecitabine- or 5-fluorouracil (5-FU)-based chemotherapy is widely used in many solid tumours, but is associated with cardiotoxicity. S-1 is a fluoropyrimidine with low rates of cardiotoxicity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13f97b5f1a9aa6049448c1fbbc3f020
http://urn.fi/urn:nbn:fi-fe2023071190533
http://urn.fi/urn:nbn:fi-fe2023071190533
Autor:
M.J.G. Bond, K. Bolhuis, O.J.L. Loosveld, H.J. Droogendijk, J.W.B. de Groot, M.P. Hendriks, B. De Valk, M.S.L. Liem, A.M. Rijken, K. Verhoef, J.H.W. de Wilt, K.P. de Jong, G. Kazemier, M.J. van Amerongen, M.R.W. Engelbrecht, J.M. Klaase, A. Komurcu, M.I. Lopez-Yurda, R-J. Swijnenburg, C.J.A. Punt
Publikováno v:
Annals of Oncology. 33:S1389
Autor:
K. Zwart, F. van der Baan, M. Koopman, G. Vink, E. Wensink, C.J.A. Punt, R.J. Verheijden, R. Cohen, A. Zaanan, C. de la Fouchardiere, D. Sefrioui, T. Lecomte, T. Aparicio, D. Tougeron, J. Roodhart
Publikováno v:
Annals of Oncology. 33:S703
Autor:
W.F. Filipe, F.E. Buisman, D.J. Grünhagen, R.J. Bennink, I.HM Borel Rinkes, R.C.G. Bruijnen, O.M. van Delden, C. Grootscholten, J. Hagendoorn, N. Kok, K.F.D. Kuhlmann, M.G.E. Lam, A. Moelker, J.M.L. Roodhart, T. Buffart, R.J. Swijnenburg, M. Versleijen, E.G. Klompenhouwer, J.I. Erdmann, C.J.A. Punt, J. Emmering, C. Verhoef, M.Y.V. Homs, B. Groot Koerkamp
Publikováno v:
HPB. 24:S103-S104